While a randomized controlled trial of vitamin D 3 supplementation in COVID-19 patients didn’t yield a significant reduction ...

Vitamin D has been increasingly studied for its immunomodulatory and anti-inflammatory effects, particularly in respiratory ...

Vitamin D supplementation does not prevent COVID-19 or improve symptoms but it may help lower the risk of long COVID, a recent study suggests.

Could vitamin D influence what happens after COVID recovery? Emerging evidence hints it may not reduce severity—but could ...

A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...

In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 ...

Key Takeaways High-dose vitamin D3 supplements did not reduce the severity of COVID-19 Daily vitamin D use failed to lower ...

A randomized trial found that high-dose vitamin D3 did not reduce COVID-19 severity, healthcare visits, or infection rates among household contacts. However, participants who adhered to supplements ...

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

Vitamin D didn’t blunt COVID’s initial impact—but it may hold a surprising clue in the fight against long COVID.

While vitamin D3 does not improve immediate COVID-19 outcomes or reduce medical visits, it may lower the risk of developing long COVID.

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.